论文部分内容阅读
为了了解在高海拔地区使用尿激酶静脉内溶栓治疗急性心肌梗塞（AMI）的效果。回顾性分析了1989～1996年6月间在我院心内科和急诊科接受尿激酶（UK）静脉内溶栓治疗的73例AMI者的临床资料。治疗结果显示：溶栓后再灌注率为49．3％（36／73），再灌注患者并发症的发生本及住院病死率明显低于血管来再道者（P＜0．05）。说明UK对高原地区的AMI也有较好疗效。
To understand the effect of intravenous thrombolysis with urokinase in acute myocardial infarction (AMI) at high altitudes. The clinical data of 73 AMI patients receiving urokinase (UK) intravenous thrombolytic therapy in the Department of Cardiology and Emergency Medicine of our hospital from 1989 to June 1996 were retrospectively analyzed. The results of the treatment showed that the rate of reperfusion after thrombolysis was 49.3% (36/73). The incidence of complications and in-hospital mortality in reperfusion patients was significantly lower than that in blood vessels (P <0.05). It shows that UK also has better curative effect on AMI in plateau area.